Newsfeeds - Spark Newswire

3 minute read

enVVeno Medical Successfully Passes Preliminary FDA Safety Review For The VenoValve U.S. Pivotal Study

Today, 5:22 AM

The Company submitted safety data for the first 20 patients enrolled in the ongoing SAVVE U.S. pivotal study for the VenoValve Following the initial safety data review by the FDA, the SAVVE study is cleared to continue

NVNO

24 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 5:22 AM

On Friday, 422 stocks made new 52-week lows.

AAT

1 minute read

News

enVVeno Medical Announces New U.S. VenoValve(R) Patent

By Benzinga Newsdesk

Today, 5:22 AM

- Expanding patent portfolio bolsters protection of the Company's lead product -The VenoValve is a potential first-in-class treatment for patients suffering from Chronic Venous Insufficiency (CVI) of the deep veins

NVNO

4 minute read

50 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:22 AM

Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares gained 81.3% to close at $2.32 on Monday. Last week, AMC Entertainment Holdings purchased a major stake in Hycroft Mining Holding.

ALRN

1 minute read

Uncategorized

enVVeno Medical Corporation Completes Rebrand

By Bill Haddad

Today, 5:22 AM

enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, announced today that it has successfully completed

HJLI

Latest news

enVVeno Medical Successfully Passes Preliminary FDA Safety Review For The VenoValve U.S. Pivotal Study

Stocks That Hit 52-Week Lows On Friday

enVVeno Medical Announces New U.S. VenoValve(R) Patent

50 Biggest Movers From Yesterday

enVVeno Medical Corporation Completes Rebrand